New research suggests use of PET/CT imaging can help identify neurological changes that can signal increased risk of Takotsubo cardiomyopathy, which is commonly referred to as broken heart syndrome.
This article was originally published on DiagnosticImaging.com.
New research from Massachusetts General Hospital found PET/CT has now shown that changes in the brain due to stress are a contributing factor to Takotsubo cardiomyopathy (TTS).
Often referred to as "Broken Heart Syndrome", results of the recent study suggest providers can see the stress-related uptick of activity in the brain’s amygdala region that can increase a patient’s risk and knowing more about this connection can help improve care for at-risk individuals.
Severe emotional distress, such as grief, anger, or fear, as well as happiness, can trigger the sudden weakening of the heart muscles that cause the swelling at the bottom of the left ventricle while the neck remains narrow. All of these emotions originate in the amygdala, the brain region that also controls the heart and nervous system.
“We show that TTS happens not only because one encounters a rare, dreadfully disturbing event – such as the death of a spouse or child, as the classical examples have it,” said team leader senior author Ahmed Tawakol, MD, director of nuclear cardiology and co-director of the Cardiovascular Imaging Research Center at MGH. “Rather, individuals with high stress-related brain activity appear to be primed to develop TTS – and can develop the syndrome upon exposure to more common stressors, even a routine colonoscopy or a bone fracture.”
TTS can cause heart attacks and death, and it is more common in women with only 10 percent of cases occurring in men. But, how does stress actually leads to TTS? Based on their investigation, the team believes they have pinpointed how the brain contributes. Kick-starting stress-sensitive tissues in the brain could be the first step, they said, because doing so releases stress hormones that ignite the sympathetic nervous system that emits inflammatory cells.
“[Our] study suggests that the increased stress-associated neurobiological activity in the amygdala, which is present years before TTS occurs, may play an important role in its development and may predict the timing of the syndrome,” Takawol explained. “It may prime an individual for a heightened acute stress response that culminates in TTS.”
To determine if TTS patients experience brain activity changes, Takawol’s team examined PET/CT scans from 104 people with an average age of 68 imaged between 2005 and 2019. Women made up 72 percent of the group. It is the first study to use PET/CT to evaluate brain activity prior to the development of TTS.
According to their evaluation, 41 people went on to develop TTS between six months to five years after the scan, but 63 didn’t. For the entire group, the time between scan, TTS onset, and the last scan or death was, on average, 2.5 years.
The team found that patients who did develop TTS had higher stress-related activity in the amygdala on their first can than those who did not develop it – and the higher the amygdala signal, the more significant the TTS risk. In fact, the top 15 percent of patients with the highest amygdala activity developed TTS within a year of imaging, they said.
Other factors also appeared to be at play in increasing a patient’s risk for TTS, including autoimmune disease, hyperlipidemia, smoking, and cancer.
In addition, Takawol’s team pinpointed a relationship between stress-related brain activity and bone marrow activity. This connection can be significant for cardiovascular health because bone marrow produces various types of blood cells that are involved with carrying oxygen, mounting immune responses, and clotting blood.
A link between the brain and the heart has long been postulated as an integral part of TTS development, said a team led by Hideaki Suzuki, an assistant professor at Tohoku University Graduate School of Medicine in Japan. Consequently, this study opens the door for further investigation into how best to reduce the brain’s stress-related activities.
“Heightened stress-associated neural activity may represent a therapeutic target to reduce TTS, as well as other stress-related cardiovascular diseases, including chronic heart failure,” said Suzuki’s team in an accompanying editorial.
Ultimately, Takawol said he hopes these findings will feed into that goal, leading to improved therapies, including drug interventions.
“Studies should test whether such approaches to decrease stress-associated brain activity decrease the chance that TTS will recur among patients with prior episodes of TTS,” he said.